sitefansalaran Exclusive Interview

  We Must Consider National Efficiency in All Matters An exclusive interview with Dr. Seyed Ebrahim Hashemi, Chairman of the Board of Directors, Association of Pharmaceutical and Human Supplement Distribution Industry (Iran) Editor’s Note: I had seen Dr. Hashemi once or twice at various events. I admired his dedication and insight and wished to engage in a meaningful conversation with a man who truly understands the values of life and responsibility—someone who could be a role model not just for his community, but perhaps far beyond. When the opportunity finally came to meet him, our respect only grew deeper. While there are many competent individuals in the country’s pharmaceutical sector, it is rare to find someone who consistently proves himself through his presence, whose words carry weight, and whose character is defined by the responsibility he upholds. One can choose the comfort of shadows, indulging in worldly pleasures, or barter life for empty embellishments—but not him. I came to realize that Dr. Hashemi perceives the value of a meaningful life like a celebrated artist, a rare quality that elevates my filmmaker's mind to the realm of greatness. In this headline-rich interview, we present his direct words without our questions interspersed. Editor-in-Chief Dr. Seyed Ebrahim Hashemi: I was born in...

Sure! Here's the English translation of the full text, as requested, with no additions: I Owe Everything to the Great Professors of Pharmacy in Iran An exclusive interview with Dr. Amirhossein Hajimiry – Fansalaran Introduction: You really need to meet Dr. Amirhossein Hajimiry in person to understand the true meaning of “character.” We briefly worked together, and one memorable spring afternoon, standing at the entrance of a major pharmaceutical company, we spoke about the current state of affairs—it felt like a cinematic moment unfolding before us. It reminded me of the closing scene of the iconic film Casablanca, when Rick (Humphrey Bogart) tells Captain Renault (Claude Rains): “This is the beginning of a beautiful friendship.” It was a strange, poetic feeling (and in the words of the film Breakfast with Giraffes — dark!) to recall such a legendary line from cinema history right at the gates of a pharmaceutical firm. A year later, when both of our paths had shifted, Dr. Hajimiry graciously agreed to collaborate with us—he became a cherished colleague of our emerging journal, Fansalaran. Respect to him. Turns out, he’s not the type to fuss about rewards or recognition. With remarkable discipline, he contributed columns and articles that became foundational pillars of the journal—without ever...

  Continuous Improvement for Better Outcomes A conversation with Morteza Ayyani, CEO of ChlorPars Company Note: In recent months, ChlorPars Company has taken significant steps—especially in terms of system upgrades, green space development, and equipment overhauls. It has also experienced a notable growth of 15 trillion IRR in the capital market. Here’s our conversation with Morteza Ayyani, CEO of ChlorPars (based in Tabriz), a subsidiary of TPPH (Tamin Pharmaceutical Investment Co.). (Questions have been omitted for brevity.) Morteza Ayyani: As you know, ChlorPars is a technically proficient company producing a wide range of products including perchlorine, ferric chloride, hydrogen peroxide, caustic soda, chlorinated paraffin, caustic potash, sodium hypochlorite, hydrogen, and more. Among these, hydrogen peroxide (industrial grade) and chlorinated paraffin are exclusive to ChlorPars and are produced only by us at a level comparable to international standards like EOP. Over the past two months, we have successfully launched pilot-scale semi-industrial production of food-grade hydrogen peroxide, and we aim to integrate it into full-scale production within the next two months upon receiving the necessary permits. The financial performance of ChlorPars has improved significantly over the past four months, with a valuation increase of 1,000 billion IRR, according to the Securities and Exchange Organization. This success is attributed to strategic...

  The Only Producer of Polyvinylpyrrolidone (PVP) in the Middle East During the Extraordinary General Assembly of Rahavard Tamin Pharmaceutical Company, an opportunity arose for Dr. Ahmadreza Taheri, the company’s CEO, to share the latest updates regarding its recent activities: “Rahavard Tamin” is known as a producer of PVP and acrylate-based products, and virtually all pharmaceutical companies in the country seek out our raw materials. I must emphasize that we are the only producer of polyvinylpyrrolidone (PVP) in Iran and the Middle East. The main purpose of the General Assembly was to restructure the company’s finances, and considering the company’s profitability, a capital increase was necessary. Another key topic was the PVP expansion project, for which part of the capital increase has been allocated as project funding. We are also seriously pursuing GMP development plans, and in the coming years, we will work on infrastructure projects, including the construction of gas and solar power plants. A 970% capital increase—funded through retained earnings and asset revaluation—was approved with the consent of the shareholders. Let me know if you'd like a shortened version for media, a press release, or a LinkedIn-style post.